. 2020 Sep 9;8:e9945. doi: 10.7717/peerj.9945

Table 2. Initial laboratory indices of patients infected with COVID-19.

Laboratory Indices	Reference values	Number of all patients	Median (IQR)	Number of patient with value deviation from reference (%)
Hematology
White blood cells, ×10⁹/mL	3.5–9.5	126	6.14 (3.96–8.29)	26 (20.6)^a
Neutrophils, ×10⁹/mL	1.8–6.3	126	4.51 (2.77–7.34)	41 (32.5)^a
Lymphocytes, ×10⁹/mL	1.1–3.2	126	0.73 (0.53–1.01)	102 (81.0)^b
Monocytes, ×10⁹/m L	0.1–0.6	126	0.29 (0.20–0.43)	6 (4.8)^a
NLR	NA	126	5.99 (3.07–12.59)
LMR	NA	126	2.39 (1.65–3.68)
CD4+ Tlym, ×10⁶/mL	450–1,440	116	142.16 (78.50–271.84)	108 (93.1)^b
CD8+ Tlym, ×10⁶/mL	320–1250	116	109.84 (61.35–154.52)	108 (93.1)^b
Th/Ts	1.5–2.9	116	1.52 (0.96–2.08)	55 (51.9)^b
CD45, ×10⁶/mL	NA	116	481.92 (338.36–724.95)
Biochemical analysis
AST, U/L	15–40	126	27.5 (19–44)	48 (38.1)^a
ALT, U/L	9–50	126	25 (15–43.5)	22 (17.5)^b
TG, mmol/L	0.45–1.69	126	1.49 (1.16–1.89)	41 (32.5)^a
Creatine, μM	57–111	126	66 (54–81.25)	7 (5.6)^a
TnI, μg/L	0–0.6	91	0.03 (0.03–0.03)	1 (1.1)^a
Myo, ng/mL	0–80	111	27.2 (18.1–38.05)	13 (11.7)^a
CK, U/L	0–171	119	63.2 (35.25–138.05)	18 (15.1)^a
CK-MB, ng/m L	0–2.37	92	1.1 (1–2.33)	23 (25.0)^a
BNP, ng/mL	0–100	88	196.5 (42.25–754.25)	53 (60.2)^a
CEA , μg/L	0–5	57	2.08 (1.51–5.53)	15 (26.3)^a
LDH, U/L	120–150	126	306.50 (241–389)	123 (97.6)^a
Infection indices
CRP, mg/L	0–5	126	40.31 (21.27–86.56)	166 (85.6)^a
PCT, ng/mL	0–0.5	121	0.04 (0.04–0.08)	5 (4.1)^a
Coagulation function
PT, s	9–13	126	13.6 (11.3–41.2)	61 (48.4)^a
APTT, s	20–40	126	35.5 (22.4–69.9)	22 (17.4)^a
TT, s	14–21	126	16.3 (12.8–72.3)	3 (2.4)^a
INR	0.8–1.25	126	1.10 (0.86–4.33)	7 (5.6)^a
FIB, g/L	2–4	126	4.79 (1.01–37.9)	83 (65.9)^a
D-Dimer, mg/L	0–0.2	126	1.96 (0.03–60.14)	96 (76.2)^a

Notes:

Above reference.

Below reference.

IQR, interquartile range; NLR, neutrophil lymphocyte ratio; LMR, lymphocyte monocyte ratio.